Yongsheng Li

Prof. Dr. Yongsheng Li

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MLMeiting Liang
Meiting Liang
XLXingxing Liu
Xingxing Liu
MSMeng Sun
Meng Sun
JZJun Zhu
Jun Zhu
SYShanshan Yang
Shanshan Yang
YLYongsheng Li
Yongsheng Li
The relationship between the single nucleotide polymorphism (SNP) at the rs2231142 locus of the Adenosine triphosphate-binding cassette transporter G subfamily member 2 (ABCG2) gene and susceptibility to hyperuricemia (HUA) is to be investigated, alongside an analysis of the associated risk factors for HUA. Venous blood samples were obtained from 1612 patients diagnosed with HUA and 1770 individuals exhibiting normal uric acid (UA) levels. Deoxyribonucleic acid was isolated, followed by amplification of the target gene via polymerase chain reaction. The genotype at the ABCG2 gene rs2231142 locus were determined using the enhanced multiplex ligation detection reaction method. Serum concentrations of UA, glucose, blood urea nitrogen (BUN), creatinine (CREA), triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol (LDL-C) were assessed in both groups. Clinical data were compiled. LASSO regression and multivariate logistic regression analyses were conducted to identify independent risk factors for HUA. A predictive model for HUA that integrates the SNP at the ABCG2 gene rs2231142 locus was developed. The model’s accuracy in predicting HUA was evaluated through the receiver operating characteristic (ROC) curve. The frequencies of the GG, GT, and TT genotypes at the rs2231142 locus of the ABCG2 gene in the male control and HUA groups were 66.2% and 60.3%, 29.2% and 35.5%, 4.6% and 4.3% (P = 0.012). These frequencies were markedly different from those of the female control and HUA groups, which exhibited 68.5% and 58.2%, 29.2% and 36.0%, 2.3% and 5.8% (P < 0.001). Regression analysis revealed seven independent risk factors for HUA: waist-to-hip ratio (WHR), BUN, TG, TC, LDL-C, and the rs2231142 G/T and T/T genotypes. For every unit increase in WHR, BUN, TG, and LDL-C, the odds of developing HUA increased by 1.794, 1.166, 1.421, and 1.286 times, respectively. A significant association was found between HUA risk and the rs2231142 G/T and T/T genotypes. Individuals harboring the rs2231142 G/T mutation exhibited a 1.192 times greater likelihood of developing HUA compared to those without the mutation, while those with the T/T genotype had a risk increase of 2.557 times. A diagnostic model for HUA was developed utilizing these risk factors, with performance assessed through the ROC curve. The area under the curve was measured at 74.8%, indicating that the model incorporating the ABCG2 gene rs2231142 locus possesses diagnostic efficacy for early prediction of HUA. Male HUA patients with the TT genotype at the ABCG2 gene rs2231142 locus displayed markedly elevated CREA levels (87.051 ± 36.378 μmol/L) in comparison to homozygous G/G (82.128 ± 39.482 μmol/L) and heterozygous G/T carriers (81.733 ± 35.926 μmol/L). A higher frequency of the T allele mutation at the rs2231142 locus of the ABCG2 gene is observed in HUA patients. Individuals possessing the rs2231142 T allele demonstrate an increased probability of developing HUA, potentially more pronounced in females. The model integrating the rs2231142 T allele locus with associated clinical risk factors exhibits diagnostic efficacy for the early prediction of HUA occurrence. Additionally, the mutation at the ABCG2 gene rs2231142 locus may influence serum CREA levels.

27 March 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
YLYongsheng Li
Yongsheng Li
YLYongnan Li
Yongnan Li
NDNing Deng
Ning Deng
HSHaonan Shi
Haonan Shi
SCSiqingaowa Caika
Siqingaowa Caika
GSGan Sen
Gan Sen
Background: Diabetic peripheral neuropathy (DPN) is a critical clinical disease with high disability and mortality rates. Early identification and treatment of DPN is critical. Our aim was to train and externally validate a prediction nomogram for early prediction of DPN. Methods: 3012 patients with T2DM were retrospectively studied. These patients were hospitalized between 1 January 2017 and 31 December 2020 in the First Affiliated Hospital of Xinjiang Medical University in Xinjiang, China. A total of 901 patients with T2DM from the Suzhou BenQ Hospital in Jiangsu, China who were hospitalized between 1 January 2019 and 31 December 2020 were considered for external validation. The least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression were performed to identify independent predictors and establish a nomogram to predict the occurrence of DPN. The performance of the nomogram was evaluated using a receiver operating characteristic curve (ROC), a calibration curve, and a decision curve analysis (DCA). Findings: Age, 25-hydroxyvitamin D3 [25(OH)D3], Duration of T2DM, high-density lipoprotein (HDL), hemoglobin A1c (HbA1c), and fasting blood glucose (FBG) were used to establish a nomogram model for predicting the risk of DPN. In the training and validation cohorts, the areas under the curve of the nomogram constructed from the above six factors were 0.8256 (95% CI: 0.8104–0.8408) and 0.8608 (95% CI: 0.8376–0.8840), respectively. The nomogram demonstrated excellent performance in the calibration curve and DCA. Interpretation: This study has developed and externally validated a nomogram model which exhibits good predictive ability in assessing DPN risk among the type 2 diabetes population. It provided clinicians with an accurate and effective tool for the early prediction and timely management of DPN.

7 January 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
YLYongnan Li
Yongnan Li
YLYongsheng Li
Yongsheng Li
GSGan Sen
Gan Sen
BHBin Hu
Bin Hu
Background: Diabetic peripheral neuropathy (DPN) is a prevalent and highly disabling complication of diabetes mellitus, associated with markedly increased rates of disability and mortality. Timely intervention and effective management have been consistently shown to substantially reduce the risk of DPN onset and progression. Methods: This retrospective cohort study analyzed 1, 004 hospitalized patients with type 2 diabetes mellitus (T2DM) admitted to the endocrinology department of a hospital in Jiangsu Province, China. A risk prediction model for DPN was developed using the Random Forest (RF) algorithm, while logistic regression analysis was employed to identify the major risk factors. The overarching aim was to provide a reliable risk assessment tool for clinical application. Findings: Five principal factors were identified as significantly associated with DPN risk: age (OR = 1.257, 95% CI [1.188–1.367], p < 0.001), serum 25(OH)D3 levels (OR = 0.791, 95% CI [0.759–0.854], p < 0.001), duration of diabetes (OR = 1.431, 95% CI [1.285–1.617], p < 0.001), glycated hemoglobin (HbA1c) (OR = 1.236, 95% CI [1.197–1.391], p < 0.001), and glycated serum protein (GSP) (OR = 1.091, 95% CI [1.047–1.201], p = 0.017). A DPN risk prediction model incorporating these variables achieved an area under the receiver operating characteristic curve (AUC) of 0.829 (95% CI: 0.802–0.857), demonstrating excellent discriminatory performance. Interpretation: The Random Forest–based DPN risk prediction model successfully identified five critical risk factors, offering a solid theoretical foundation for personalized strategies in DPN prevention and management among patients with diabetes. This model exhibits high predictive utility in clinical practice.